Notification

Error

Diagnosed de novo metastatic hormone-sensitive: My experience with early 177Lu-PSMA

User
Posted 18 Jul 2026 at 15:27

Hello everyone,

I wanted to share a brief update on my journey in the hope it might help others looking into advanced staging and early theranostics.

A couple of years ago, I had a highly suspicious PI-RADS 5 lesion on an MRI, but a targeted biopsy came back completely negative. My local doctors told me not to worry, but my PSA kept rising. Trusting the data trend, I pushed for a private 18F-PSMA PET scan. It completely changed my staging, revealing a dominant metastasis in my pelvic bone before the cancer had breached the prostate capsule.

After doing extensive research as a scientist, I chose to look outside standard protocols. I traveled to a specialist theranostics clinic in Germany to receive Lutetium-177 PSMA radioligand therapy early, while my disease was still hormone-sensitive. We also ran a genomic liquid biopsy and found I carry a somatic FANCA mutation, which likely made the cancer highly sensitive to the radiation.

After just two cycles of Lutetium alongside an anti-androgen, my PSA became completely undetectable (<0.01) and my latest follow-up PSMA-PET scans show a complete molecular response—the bone metastasis has completely disappeared. I'm currently dealing with the standard intense fatigue from the hormone blockade, and my oncologist and I are discussing safely de-escalating treatment soon to get my quality of life back.

I'm currently co-authoring a formal medical case report on this protocol with my treating professor in Germany. If anyone is navigating a false-negative biopsy, dealing with hormone-sensitive metastatic disease, or considering traveling for early radioligand therapy, I’d be very glad to share what I've learned about the process.

User
Posted 18 Jul 2026 at 16:07

Originally Posted by: Online Community Member
After just two cycles of Lutetium alongside an anti-androgen, my PSA became completely undetectable (<0.01) and my latest follow-up PSMA-PET scans show a complete molecular response—the bone metastasis has completely disappeared. I'm currently dealing with the standard intense fatigue from the hormone blockade, and my oncologist and I are discussing safely de-escalating treatment soon to get my quality of life back.

Hello Crispin

I'm not a scientist, but I'm rejoicing in your good news. I hope that the treatment can be adjusted to improve your quality of life.

User
Posted 29 Jul 2026 at 10:24

Originally Posted by: Online Community Member

Hello everyone,

I wanted to share a brief update on my journey in the hope it might help others looking into advanced staging and early theranostics.

A couple of years ago, I had a highly suspicious PI-RADS 5 lesion on an MRI, but a targeted biopsy came back completely negative. My local doctors told me not to worry, but my PSA kept rising. Trusting the data trend, I pushed for a private 18F-PSMA PET scan. It completely changed my staging, revealing a dominant metastasis in my pelvic bone before the cancer had breached the prostate capsule.

After doing extensive research as a scientist, I chose to look outside standard protocols. I traveled to a specialist theranostics clinic in Germany to receive Lutetium-177 PSMA radioligand therapy early, while my disease was still hormone-sensitive. We also ran a genomic liquid biopsy and found I carry a somatic FANCA mutation, which likely made the cancer highly sensitive to the radiation.

After just two cycles of Lutetium alongside an anti-androgen, my PSA became completely undetectable (<0.01) and my latest follow-up PSMA-PET scans show a complete molecular response geometry dash —the bone metastasis has completely disappeared. I'm currently dealing with the standard intense fatigue from the hormone blockade, and my oncologist and I are discussing safely de-escalating treatment soon to get my quality of life back.

I'm currently co-authoring a formal medical case report on this protocol with my treating professor in Germany. If anyone is navigating a false-negative biopsy, dealing with hormone-sensitive metastatic disease, or considering traveling for early radioligand therapy, I’d be very glad to share what I've learned about the process.

Wishing you continued strength and the very best on your journey. Thanks you so much!

Edited by member 31 Jul 2026 at 03:52  | Reason: Not specified

User
Posted 29 Jul 2026 at 23:00
Great update thanks
User
Posted 30 Jul 2026 at 06:24
Thank you so much for sharing Crispin. Hoping for the best for you. Do the doctors say if the FANCA mutation also sensitize to Olaparib? Hope you never need it but that it s an option if you do later on.
User
Posted 30 Jul 2026 at 06:41

if the FANCA mutation also sensitize to Olaparib?

Yes -  this is an option that can be used in the future if needed...

 

 
Forum Jump  
©2026 Prostate Cancer UK